Axonics modulation technologies, inc. (AXNX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Dec'17
ASSETS
Current assets
Cash and cash equivalents

159,820

171,082

76,231

82,680

89,334

98,306

20,148

24,398

Short-term investments

0

12,592

25,311

43,001

54,819

59,218

11,069

0

Accounts receivable, net of allowance for doubtful accounts of $589 and $75 at March 31, 2020 and December 31, 2019, respectively

20,770

7,879

954

1,286

804

427

219

0

Inventory, net

19,230

15,659

12,703

7,975

5,064

3,673

2,148

1,541

Prepaid expenses and other current assets

4,245

4,468

2,625

3,074

2,778

3,716

1,751

980

Total current assets

204,065

211,680

117,824

138,016

152,799

165,340

35,335

26,919

Property and equipment, net

5,406

3,047

2,952

3,000

2,887

2,784

2,817

1,530

Intangible asset, net

282

311

340

368

397

426

455

541

Other assets

7,626

4,784

4,928

5,068

3,344

3,356

3,712

422

Total assets

217,379

219,822

126,044

146,452

159,427

171,906

42,319

29,412

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable

7,440

5,882

4,232

3,185

2,102

3,436

1,983

1,616

Accrued liabilities

3,110

2,174

4,304

3,630

2,364

1,019

2,713

789

Accrued compensation and benefits

3,503

3,375

-

-

-

664

-

-

Operating lease liability, current portion

794

602

625

588

523

768

800

0

Debt, current portion

5,000

0

6,382

3,897

1,705

-

-

-

Total current liabilities

19,847

12,033

15,543

11,300

6,694

5,887

5,496

2,405

Operating lease liability, net of current portion

9,485

4,450

4,573

4,739

3,476

3,281

3,453

135

Debt, net of unamortized debt issuance costs, net of current portion

15,571

20,336

13,740

16,000

17,923

19,463

9,056

0

Total liabilities

44,903

36,819

33,856

32,039

28,093

28,631

18,005

2,540

Noncontrolling interest in Axonics Europe, S.A.S.

-

-

-

-

-

-

31,066

31,066

Stockholders’ equity
Preferred stock, par value $0.0001 per share; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

-

0

Common stock, par value $0.0001, 50,000,000 shares authorized at March 31, 2020 and December 31, 2019; 34,510,662 and 34,110,995 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

3

3

3

3

3

3

0

0

Additional paid-in capital

367,278

363,012

249,599

246,706

244,523

243,337

3,336

2,900

Stockholders' Equity Note, Subscriptions Receivable

-

-

-

-

-

-

1,824

1,753

Accumulated deficit

-194,200

-179,584

-156,833

-131,827

-112,766

-99,649

-89,984

-67,166

Accumulated other comprehensive loss

-605

-428

-581

-469

-426

-416

-406

-402

Total stockholders’ equity

172,476

183,003

92,188

114,413

131,334

143,275

-88,878

-66,421

Total liabilities and stockholders’ equity

217,379

219,822

126,044

146,452

159,427

171,906

42,319

29,412

Series A Preferred Stock [Member]
Convertible Preferred Stock

-

-

-

-

-

-

-

14,021

Series B-1 Preferred Stock [Member]
Convertible Preferred Stock

-

-

-

-

-

-

-

13,757

Series B-2 Preferred Stock [Member]
Convertible Preferred Stock

-

-

-

-

-

-

-

17,572

Series C Preferred Stock [Member]
Convertible Preferred Stock

-

-

-

-

-

-

-

16,877